Description
To investigate the following matters under post-marketing use of Lorbrena in patients who received this drug
Factors affecting the onset of central nervous system disorder
Effect of Lorbrena in combination with CYP3A inducers on the onset of hepatic dysfunction
Information
Condition
Non-small Cell Lung Cancer
Number of study visits
3-5
Length of studies
varies
Long-term follow-up
two times after finishing the stuy
Sex
Male, Female
Payment
Yes
Location
Address
Copenhagen
Contact Information
Email
Website